RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE OESOPHAGITIS [ZASTAPRAZAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]

Jung-Hwan Oh  ¹     Hyun-Soo Kim  ²     Dae Young Cheung  ³     Hang Lak Lee  ⁴     Dong-Ho Lee  ⁵     Gwang Ha Kim  ⁶     Suck-Chei Choi  ⁷     Yu Kyung Cho  ⁸     Woo-Chul Chung  ⁹     Ji Won Kim  ¹⁰     Eunju Yu  ¹¹     Hyesoo Kwon  ¹¹     John Kim  ¹¹     Hwoon-Yong Jung  ^12    
1 Eunpyeong St. Mary's Hospital, Seoul, Korea, Republic of
² Yonsei University, Wonju College of Medicine, Wonju, Korea, Republic of
³ College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
⁴ Hanyang University Hospital, Seoul, Korea, Republic of
⁵ Seoul Natl University Bundang Hospital, Division of Gastroenterology, Seongnam, Korea, Republic of
⁶ Pusan National University School of Medicine, Busan, Korea, Republic of
⁷ Wonkwang University Hospital, Iksan, Korea, Republic of
⁸ The Catholic University of Korea, Seoul, Korea, Republic of
⁹ The Catholic University of Korea, St. Vincents Hospital, Suwon, Korea, Republic of
¹⁰ SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of
¹¹ Onconic Therapeutics, Seoul, Korea, Republic of
¹² Asan Medical Center, Seoul, Korea, Republic of

Topic
Digestive Oncology, Oesophagus, Surgery

Session
What is new in GORD management: Drugs or surgery?

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)